Sharps Technology, Inc. (NASDAQ:STSS) Sees Significant Decline in Short Interest

Sharps Technology, Inc. (NASDAQ:STSS) was the recipient of a large drop in short interest in the month of December. As of December 31st, there was short interest totalling 110,000 shares, a drop of 19.8% from the December 15th total of 137,200 shares. Currently, 6.4% of the shares of the company are short sold. Based on an average daily trading volume, of 178,600 shares, the short-interest ratio is presently 0.6 days.

Sharps Technology Stock Down 4.0 %

STSS opened at $1.94 on Wednesday. The stock’s fifty day moving average price is $2.47. The firm has a market capitalization of $3.97 million, a P/E ratio of -0.24 and a beta of 1.56. Sharps Technology has a fifty-two week low of $1.70 and a fifty-two week high of $18.15.

Hedge Funds Weigh In On Sharps Technology

An institutional investor recently bought a new position in Sharps Technology stock. Garden State Investment Advisory Services LLC bought a new position in shares of Sharps Technology, Inc. (NASDAQ:STSS) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 172,909 shares of the company’s stock, valued at approximately $26,000. Garden State Investment Advisory Services LLC owned 8.45% of Sharps Technology at the end of the most recent quarter. 17.17% of the stock is owned by hedge funds and other institutional investors.

About Sharps Technology

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.